We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
Turnover
16.67%
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-11.07%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$122M
AUM Growth
-$26.1M
(-18%)
Cap. Flow
-$2.71M
Cap. Flow
% of AUM
-2.22%
Top 10 Holdings %
Top 10 Hldgs %
29.75%
Holding
113
New
4
Increased
25
Reduced
23
Closed
3
Avg Time Held
3.5
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.12M |
| 2 |
SRXH
SRX Global
SRXH
|
+$1.01M |
| 3 |
Rockwell Medical
RMTI
|
+$452K |
| 4 |
VEV
Vicinity Motor Corp. Common Stock
VEV
|
+$446K |
| 5 |
BNB Standard Corporation Common Stock
BNC
|
+$436K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSLT
CASTLIGHT HEALTH, INC.
CSLT
|
+$2.36M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$2.12M |
| 3 |
Standard BioTools
LAB
|
+$1.59M |
| 4 |
UPH
UpHealth, Inc.
UPH
|
+$868K |
| 5 |
Vericel Corp
VCEL
|
+$544K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 56.84% |
| 2 | Technology | 17.79% |
| 3 | Industrials | 8.45% |
| 4 | Consumer Staples | 7.61% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Idexx Laboratories
IDXX
$41.7B
| $5.91M | 4.85% |
10,805
| – | – |
2013 Q3
34 quarters
|
|
2
Microsoft
MSFT
$3.96T
| $4.78M | 3.92% |
15,493
| – | – |
2014 Q1
32 quarters
|
|
3
OptimizeRx
OPRX
$156M
| $4.05M | 3.32% |
107,330
-500
| -0.5% | -$22.1K |
2018 Q2
15 quarters
|
|
4
Eli Lilly
LLY
$1.08T
| $3.84M | 3.15% |
13,408
| – | – |
2013 Q2
35 quarters
|
|
5
Veracyte
VCYT
$3.5B
| $3.39M | 2.78% |
122,980
-750
| -0.6% | -$21.5K |
2018 Q1
16 quarters
|
|
6
Abbott
ABT
$178B
| $3.21M | 2.63% |
27,080
| – | – |
2014 Q1
32 quarters
|
|
|
7
Advanced Micro Devices
AMD
$932B
| $2.86M | 2.35% |
26,184
+17,734
| +210% | +$2.12M |
2018 Q1
16 quarters
|
|
8
Inuvo
INUV
$7.77M
| $2.84M | 2.33% |
580,503
+13,810
| +2% | +$63.8K |
2018 Q2
15 quarters
|
|
9
Pfizer
PFE
$166B
| $2.76M | 2.26% |
53,273
-975
| -2% | -$50.6K |
2013 Q2
35 quarters
|
|
10
DELISTED
Streamline Health Solutions
STRM
| $2.65M | 2.17% |
110,477
-1,800
| -2% | -$38.6K |
2018 Q2
15 quarters
|
|
11
Digi International
DGII
$2.71B
| $2.53M | 2.07% |
117,450
-3,800
| -3% | -$81.2K |
2020 Q1
8 quarters
|
|
12
Perion Network
PERI
$347M
| $2.4M | 1.97% |
106,651
-1,400
| -1% | -$29.8K |
2021 Q1
4 quarters
|
|
13
DELISTED
Edgio, Inc. Common Stock
EGIO
| $2.38M | 1.95% |
11,388
| – | – |
2021 Q4
1 quarter
|
|
14
Natera
NTRA
$56.9B
| $2.38M | 1.95% |
58,400
-1,800
| -3% | -$108K |
2018 Q2
15 quarters
|
|
15
DELISTED
FlexShopper
FPAY
| $2.3M | 1.88% |
1,342,440
-8,000
| -0.6% | -$14.2K |
2018 Q3
14 quarters
|
|
16
Axogen
AXGN
$2.06B
| $2.29M | 1.88% |
288,190
+11,000
| +4% | +$95K |
2013 Q3
34 quarters
|
|
17
AtriCure
ATRC
$2.91B
| $2.26M | 1.85% |
34,350
-4,000
| -10% | -$259K |
2013 Q2
35 quarters
|
|
18
Ooma
OOMA
$549M
| $2.25M | 1.85% |
150,425
| – | – |
2018 Q2
15 quarters
|
|
19
CareDx
CDNA
$3.35B
| $2.13M | 1.75% |
57,692
| – | – |
2017 Q3
18 quarters
|
|
20
DELISTED
Profire Energy, Inc
PFIE
| $2.02M | 1.66% |
1,557,945
| – | – |
2016 Q2
23 quarters
|
|
21
Alphatec Holdings
ATEC
$1.61B
| $2.01M | 1.65% |
174,500
+7,400
| +4% | +$80K |
2019 Q3
10 quarters
|
|
|
ATRS
22
DELISTED
Antares Pharma, Inc.
ATRS
| $1.97M | 1.62% |
481,483
+4,500
| +0.9% | +$16.3K |
2016 Q3
22 quarters
|
|
23
LeMaitre Vascular
LMAT
$1.89B
| $1.95M | 1.6% |
42,000
| – | – |
2017 Q1
20 quarters
|
|
24
AbbVie
ABBV
$501B
| $1.95M | 1.6% |
12,025
| – | – |
2019 Q1
12 quarters
|
|
|
25
Rockwell Medical
RMTI
$30.9M
| $1.95M | 1.6% |
37,547
+10,665
| +40% | +$452K |
2013 Q2
35 quarters
|
|
Similar funds
AA
WA
AC
BCVI
HAP
RHIG
CWM
SI
Perkins Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Perkins Capital Management held 113 positions worth $122M, down 18% from $148M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Perkins Capital Management's Q1 2022 filing shows 4 new, 25 increased, 23 reduced and 3 closed positions. Its largest new stake was Vicinity Motor Corp. Common Stock: 133,000 shares worth $319K. The largest sale was CASTLIGHT HEALTH, INC., an estimated $2.36M.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 60% a quarter earlier, followed by Technology and Industrials.
- Perkins Capital Management's largest Q1 2022 buy was Vicinity Motor Corp. Common Stock: 133,000 shares worth $319K.
- Perkins Capital Management added most to Advanced Micro Devices in Q1 2022, an estimated $2.12M increase.
- Perkins Capital Management's biggest Q1 2022 reduction was Standard BioTools, cutting an estimated $1.59M.
- Perkins Capital Management fully exited CASTLIGHT HEALTH, INC. in Q1 2022, selling an estimated $2.36M.
- Perkins Capital Management's ten largest holdings make up 30% of its $122M portfolio in Q1 2022.
- Perkins Capital Management opened 4 new positions and closed 3 in Q1 2022.
- Perkins Capital Management's portfolio value fell 18% quarter-over-quarter to $122M.
Based on Perkins Capital Management's 13F filing for Q1 2022, filed 20 Apr 2022.